Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2021 Mar 26;9(3):e3402.
doi: 10.1097/GOX.0000000000003402. eCollection 2021 Mar.

Results from the MemoryGel Post-approval Study

Kimberly K Short  1 , Roger N Wixtrom  2 , Megan M Estes  3 , John Leopold  4 , John W Canady  3
Affiliations

Results from the MemoryGel Post-approval Study

Kimberly K Short et al. Plast Reconstr Surg Glob Open. .

Abstract

The approval of Mentor MemoryGel Breast Implants in November 2006 was conditional on conducting a 10-year study designed to collect long-term experience in US women with MemoryGel Breast Implants, known as the MemoryGel Post-Approval Study.

Methods: This prospective, observational 10-year follow-up study used a current cohort design that began in 2007, which included both MemoryGel Breast Implant participants and concurrent saline controls to assess rheumatologic and neurologic signs and symptoms. The protocol was amended in 2015, which limited the scope of further data collection for the study to only secondary procedure/re-operation data for MemoryGel participants.

Results: Primary augmentation (n = 6743), revision augmentation (n = 2071), primary reconstruction (n = 1763), and revision reconstruction (n = 557) participants were enrolled in the Re-operation Phase Safety Set. Kaplan-Meier-estimated 10-year cumulative incidence of re-operation and explantation on a participant-level were 10.5% and 4.2% (primary augmentation), 14.1% and 7.7% (revision augmentation), 20.8% and 12.8% (primary reconstruction), and 25.0% and 16.6% (revision reconstruction).

Conclusions: The Re-operation Phase of the post-approval study addressed the Kaplan-Meier implant removal and re-operation rates over time, and provided the reasons for re-operation over time. Overall, no significant new hazards, increased risk, or unexpected adverse events were identified in the MemoryGel Post-Approval Study Re-operation Phase Safety Set.

PubMed Disclaimer

Conflict of interest statement

Disclosure: RNW is a consultant for Mentor Worldwide, LLC. MME and JWC are employees of Mentor Worldwide, LLC. JL is an employee of Depuy Synthes. This study was sponsored by Mentor Worldwide, LLC.

References

    1. Coroneos CJ, Selber JC, Offodile AC, II, et al. . US FDA breast implant postapproval studies: Long-term outcomes in 99,993 patients. Ann Surg. 2019; 269:30–36 - PubMed
    1. Ashar BS. Assessing the risks of breast implants and FDA’s vision for the national breast implant registry. Ann Surg. 2019; 269:37–38 - PubMed
    1. Colwell AS, Mehrara B. Discussion: Silicone implant illness: Science versus myth? Plast Reconstr Surg. 2019; 144:112–113 - PubMed
    1. Swanson E. The textured breast implant crisis: A call for action. Ann Plast Surg. 2019; 82:593–594 - PMC - PubMed
    1. Karlson EW, Lee IM, Cook NR, et al. . Comparison of self-reported diagnosis of connective tissue disease with medical records in female health professionals: The Women’s Health Cohort Study. Am J Epidemiol. 1999; 150:652–660 - PubMed

LinkOut - more resources